Abstract
Background
TransCelerate BioPharma has created the eSource Initiative with the intent to facilitate the industry’s movement toward optimal usage of electronic data sources. Although guidance and standards have been in place for some time, data collection methods and technology have not been utilized to their fullest capability, and transcription between electronic systems continues to be the norm.
Methods
The TransCelerate approach for the eSource Initiative is to understand the current landscape and highlight factors that are influencing the adoption of new technologies. As a preliminary step in this process, TransCelerate surveyed member companies regarding eSource usage and barriers.
Results
Literature review, stakeholder engagement, and the member survey have provided insight into the current landscape, which will help TransCelerate to develop proposals for best practices for industry utilization of electronic data collection tools and methods to benefit all stakeholders.
Conclusions
Based on survey results, companies generally have taken steps to leverage current eSource technologies and prepare for optimal utilization of electronic data sources. The TransCelerate eSource Initiative will continue to evaluate the technology, regulatory, standards, and health care landscape to support the goal of improving global clinical science and global clinical trial execution. Forthcoming publications will focus on technology landscape, future vision, and demonstration projects.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
US Food and Drug Administration. Guidance for industry: electronic source data in clinical investigations. http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm328691.pdf. Accessed July 2016.
TECHCO. Tech and the music industry: the evolution continues. http://tech.co/tech-music-industry-evolution-2015-02. Accessed July 2016.
Scranton Gillette Communications. Publisher—how technology continues to change the publishing industry. http://www.scrantongillette.com/blog/publisher-how-technology-continues-change-publishing-industry. Accessed July 2016.
Uber underlying technologies and how it actually works. https://medium.com/yalantis-mobile/uber-underlying-technologies-and-how-it-actually-works-526f55b37c6f#.fgcmi37p2. Accessed July 2016.
The role of technology in banking industry: use of technology. http://www.useoftechnology.com/role-technology-banking-industry/. Accessed July 2016.
US Food and Drug Administration. PDUFA V: information technology/informatics plan; FY 2013–FY 2017. http://www.fda.gov/downloads/ForIndustry/UserFees/PrescriptionDrugUserFee/UCM416711.pdf. Published September 2014. Accessed July 2016.
Butterfield B. eHealth Initiative & Foundation. Overview of global eHealth initiatives. http://www.himssme.org/11/programme/documents/TR5_BlairButterfield.pdf. Accessed July 2016.
US Food and Drug Administration. Guidance for industry: use of electronic health record data in clinical investigations (Draft). http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm501068.pdf. Accessed July 2016.
US Food and Drug Administration. Guidance for industry: computerized systems used in clinical investigations. http://www.fda.gov/OHRMS/DOCKETS/98fr/04d-0440-gdl0002.pdf. Accessed July 2016.
US Food and Drug Administration. Title 21—Food and Drugs: Part 11, Electronic Records; Electronic Signatures. In: Code of Federal Regulations. Washington, DC: US Department of Health and Human Services. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=11. Accessed July 2016.
European Medicines Agency. Reflection paper on expectations for electronic source data and data transcribed to electronic data collection tools in clinical trials. http://www.ema.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/2010/08/WC500095754.pdf. Accessed July 2016.
Medicines & Healthcare products Regulatory Agency. MHRA position statement and guidance electronic health records. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/470228/Electronic_Health_Records_MHRA_Position_Statement.pdf. Accessed July 2016.
eClinical Forum and PhRMA EDC/eSource Taskforce. The future vision of electronic health records as eSource for clinical research v1.0, September 2006. https://www.w3.org/wiki/images/2/21/HCLS$$ClinicalObservationsInteroperability$FutureEHR.pdf. Accessed July 2016.
Society for Clinical Data Management. eSource implementation in clinical research: a data management perspective. http://scdm.org/publications/white-papers/. Accessed July 2016.
SCDM eSource Taskforce. (2016). eSource in clinical research: A data management perspective on the use of mobile health technology [White Paper]. http://scdm.org
Clinical Data Interchange Standards Consortium. CDISC to convene eSource stakeholders group to encourage use of EHRs for research. http://www.cdisc.org/CDISC-eSource-Stakeholders-Convene. Accessed July 2016.
Health Level Seven International. HL7 partners in interoperability. http://www.hl7.org/events/partners.cfm?ref=nav. Accessed July 2016.
US Food and Drug Administration. Source data capture from electronic health records (EHRs). http://www.fda.gov/Drugs/DevelopmentApprovalProcess/FormsSubmissionRequirements/ElectronicSubmissions/ucm464653.htm. Accessed July 2016.
De Moor G, Sundgren M, Kalra D, et al. Using electronic health records for clinical research: the case of the EHR4CR project. J Biomed Inform. 2015;53:162–173.
Dugas M, Neuhaus P, Meidt A, et al. Portal of medical data models: information infrastructure for medical research and healthcare [published online February 11, 2016]. Database. 2016. doi: https://doi.org/10.1093/database/bav121.
Gupta SK. Paperless clinical trials: myth or reality? Indian J Pharmacol. 2015;47:349–353.
Dugas M. ODM2CDA and CDA2ODM: tools to convert documentation forms between EDC and EHR systems. BMC Med Inform Decis Mak. 2015;15:40.
Koppel R, Lehmann CU. Implications of an emerging EHR monoculture for hospitals and healthcare systems. J Am Med Inform Assoc. 2015;22:465–471.
Köpcke F, Trinczek B, Majeed RW, et al. Evaluation of data completeness in the electronic health record for the purpose of patient recruitment into clinical trials: a retrospective analysis of element presence. BMC Med Inform Decis Mak. 2013;13:37.
Weiskopf NG, Weng C. Methods and dimensions of electronic health record data quality assessment: enabling reuse for clinical research. J Am Med Inform Assoc. 2013;20:144–151.
Schick-Makaroff K, Molzahn A. Strategies to use tablet computers for collection of electronic patient-reported outcomes. Health Quality Life Outcomes. 2015;13:2.
International Telecommunication Union. Internet of things global standards initiative. http://www.itu.int/en/ITU-T/gsi/iot/Pages/default.aspx. Accessed July, 2016.
HealthIT.gov. Health information exchange. https://www.healthit.gov/HIE. Accessed July 2016.
Woodcock J. CDER 2016 priorities. http://www.fda.gov/downloads/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDER/UCM477299.pdf. Accessed July 2016.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Kellar, E., Bornstein, S.M., Caban, A. et al. Optimizing the Use of Electronic Data Sources in Clinical Trials: The Landscape, Part 1. Ther Innov Regul Sci 50, 682–696 (2016). https://doi.org/10.1177/2168479016670689
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1177/2168479016670689